Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely?
IO Biotech to Present at Jefferies Global Healthcare Conference
A webcast replay of the presentation will be available from the Investors section of the Company's website at for 90 days.
HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating
HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating.
IO Biotech Is Maintained at Buy by HC Wainwright & Co.
IO Biotech Is Maintained at Buy by HC Wainwright & Co.
IO Biotech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 775.91% HC Wainwright & Co. $8 → $12 Maintains Buy 03/06/2024 483.94% HC Wainwright & Co. → $8
Optimistic Buy Rating for IO Biotech Amidst Promising Clinical Trial Progress and Accelerated PFS Data Timeline
Express News | IO Biotech, Inc. : H.c. Wainwright Raises Target Price to $12 From $8
IO Biotech(IOBT.US) 10% Shareholder Sells US$802.5K in Common Stock
$IO Biotech(IOBT.US)$ 10% Shareholder Novo Holdings A/S sold 658.81K shares of common stock on May 10, 2024 at an average price of $1.2181 for a total value of $802.5K.Source: Announcement What is sta
Analysts Are Bullish on These Healthcare Stocks: IO Biotech (IOBT), Iterum Therapeutics (ITRM)
IO Biotech | 10-Q: Quarterly report
IO Biotech 1Q Loss $19.5M >IOBT
IO Biotech 1Q Loss $19.5M >IOBT
IO Biotech 1Q Loss/Shr 30c >IOBT
IO Biotech 1Q Loss/Shr 30c >IOBT
Express News | IO Biotech Inc - Ended Q1 With About $118.0 Mln in Cash and Cash Equivalents, Maintaining Expected Cash Runway Into Q4 of 2025
Express News | IO Biotech Q1 Basic EPS USD -0.3
Express News | IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
Express News | IO Biotech Q1 Net Income USD -19.457 Million
Express News | IO Biotech Q1 Pretax Profit USD -19.042 Million
Express News | IO Biotech Q1 Operating Income USD -20.197 Million
Form 144 | IO Biotech(IOBT.US) 10% Stockholder Proposes to Sell 988.21K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $IO Biotech(IOBT.US)$ 10% Stockholder Novo Holdings A/S intends to sell 658.81K shares of its common stock on May 10, with a total market value of approximately $988.21
IO Biotech Board Member Jack Nielsen Resigns Due to Health
No Data